Ben Bronstein Net Worth & Insider Trades
Ben Bronstein - Director, Aldeyra Therapeutics, Inc
What is Ben Bronstein's Net Worth?
The current estimated net worth of Aldeyra Therapeutics, Inc's Director, Ben Bronstein, is estimated to be about $133.49K . Ben Bronstein owns about 18,644 units of Aldeyra Therapeutics, Inc common stock. In the last 8 years at Aldeyra Therapeutics, Inc, Ben Bronstein has sold an estimated value of $0 worth.
What is Ben Bronstein's Past Insider Trading?
Ben Bronstein's largest purchase order was 12,500 units , worth over $100K on May 8, 2014. In total, Ben Bronstein has made about 11 transactions over 8 years of their time at Aldeyra Therapeutics, Inc. Ben Bronstein usually trades in June, with the busiest year in 2017 and 2019. The most recent transaction was a purchase order of 1,700 units , worth over $9.95K on September 19, 2019.
Ben Bronstein
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Ben Bronstein's' Mailing Address?
- Mailing address is 15 New England Executive Park Burlington MA 01803 MA
What are Aldeyra Therapeutics, Inc's Past Insider Trades?
Aldeyra Therapeutics, Inc's most recent insider trade came on August 11, 2022 by Perceptive Advisors Llc, Perceptive Life Sciences Master Fund Ltd and Joseph Edelman who bought 115,000 units worth $867.75K . In the last 8 years, insiders at Aldeyra Therapeutics, Inc have sold an estimated value of $1.97M and bought an estimated value of $73.46M worth of shares. Insider trading is most common in June, with the busiest year in 2019. The most active traders at the company are Joseph Edelman, Perceptive Advisors Llc, and Perceptive Life Sciences Master Fund Ltd .
Aldeyra Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||